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Abstract
Background: As antiretroviral therapy (ART) for HIV becomes increasingly available in low and middle income countries
(LMICs), understanding reasons for lack of adherence is critical to stemming the tide of infections and improving health.
Understanding the effect of psychosocial experiences and mental health symptomatology on ART adherence can help
maximize the benefit of expanded ART programs by indicating types of services, which could be offered in combination
with HIV care.
Methodology: The Coping with HIV/AIDS in Tanzania (CHAT) study is a longitudinal cohort study in the Kilimanjaro Region
that included randomly selected HIV-infected (HIV+) participants from two local hospital-based HIV clinics and four free-
standing voluntary HIV counselling and testing sites. Baseline data were collected in 2008 and 2009; this paper used data
from 36 month follow-up interviews (N = 468). Regression analyses were used to predict factors associated with incomplete
self-reported adherence to ART.
Results: Incomplete ART adherence was significantly more likely to be reported amongst participants who experienced a
greater number of childhood traumatic events: sexual abuse prior to puberty and the death in childhood of an immediate
family member not from suicide or homicide were significantly more likely in the non-adherent group and other negative
childhood events trended toward being more likely. Those with incomplete adherence had higher depressive symptom
severity and post-traumatic stress disorder (PTSD). In multivariable analyses, childhood trauma, depression, and financial
sacrifice remained associated with incomplete adherence.
Discussion: This is the first study to examine the effect of childhood trauma, depression and PTSD on HIV medication
adherence in a low income country facing a significant burden of HIV. Allocating spending on HIV/AIDS toward integrating
mental health services with HIV care is essential to the creation of systems that enhance medication adherence and
maximize the potential of expanded antiretroviral access to improve health and reduce new infections.
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Introduction
Globally, an estimated 33.4 million people are living with HIV
infection, with over two-thirds living in sub-Saharan Africa (SSA).
With the allocation of donor resources through the Global Fund to
Fight AIDS, Tuberculosis, and Malaria, the US President’s
Emergency Plan for AIDS Relief (PEPFAR), and the World Bank
Multi-Country AIDS Program, the number of people receiving
antiretroviral therapy (ART) in less wealthy nations has increased
from roughly 400,000 in 2003 to more than 8 million in 2012 [1].
In Tanzania, about 370,000 people, or 20% of the estimated
1.4 million people eligible for ART, are receiving treatment [2].
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Recent guidelines, which recommend earlier initiation of ART at
a CD4 cell count of 350 cells/mm3, are expected to rapidly
increase the number of persons on ART over the next several
years. The recent Institute of Medicine (IOM) evaluation of
PEPFAR, while lauding many successes of the program, identified
as an essential need the focus on improved medication adherence
among patients [3].
Crucial to the success of ART is strict adherence to prescribed
medication regimens. Incomplete adherence leads to drug
resistance [4,5] immunologic decline [6], faster progression of
disease [7], and death [8]. Incomplete adherence has been a major
challenge in HIV treatment worldwide, with adherence in the US
estimated at 55% and, in SSA approximately 77% [9]. Higher
adherence rates in SSA have dispelled doubts that ART would not
be feasible in such resource-constrained settings and have pointed
to the importance of tight social relationships in mediating
adherence [10]. However, longitudinal data are sparse, and
existing adherence studies are primarily among relatively new
initiates of ART [7,8]. Longer time on medication has been
correlated with declining adherence in SSA [11]. In the
Kilimanjaro region, Ramadhani et al. demonstrated that despite
relatively high rates of adherence among patients who had been
receiving ART for 6 months or longer, lack of complete virologic
suppression was identified in 32% and ART resistance was
identified in 10% of 150 patients [12].
In wealthier nations, psychosocial characteristics including
having experienced past potentially traumatic events, life events,
depression, anxiety, stress, beliefs about the efficacy of therapy,
and patient-provider relationships are highly correlated with
adherence [12,13,14]. Our own work has highlighted the
importance of past traumatic events, depression and anxiety on
ART adherence in the United States [15]. A recent qualitative
study, in which 61 Tanzanian adults prescribed ART were
interviewed about determinants of adherence found that psycho-
social characteristics including religious beliefs, support from
family and friends, and stigma influenced patients’ beliefs and
motivation about ART adherence [16]. Baseline findings from the
CHAT study found high rates of exposure to potentially traumatic
events [17].
This study examines associations among stressful and potentially
traumatic events, current depressive symptoms and post-traumatic
stress symptomatology, resource constraints as measured by
having to make trade-offs between health care and other needs,
social support, demographics, and adherence to ART among
HIV+ clients in care at two regional hospitals and in four
voluntary HIV counselling and testing sites. While adherence to
ARTs in less wealthy nations is possible and high rates can be
achieved, the authors hypothesize that, as in wealthy nations, the
experience of potentially traumatic events and the mental health
symptomatology of depression and anxiety will be associated with
higher likelihood of incomplete adherence over time.
Methods
This study and all study activities were approved by the
Institutional Review Boards at Duke University in Durham, North
Carolina, USA, the Kilimanjaro Christian Medical College and
the National Medical Research Institute in Tanzania, and written
consent was obtained from all participants.
CHAT is a longitudinal cohort study with the primary aim of
understanding if, and to what extent, self-reported HIV medica-
tion adherence in a low income country is related to psychosocial
factors such as potentially traumatic experiences, depression, post-
traumatic stress symptomatology, and social support, as well as
other socioeconomic and demographic factors. CHAT partici-
pants were enrolled in the study beginning in November 2008.
Enrolment included 499 randomly selected HIV+ persons from
the two local hospital-based HIV clinics and 267 newly diagnosed
HIV+ persons randomly selected from four free-standing volun-
tary HIV counselling and testing (VCT) sites. These analyses
included those interviewed at 36 months: 438 from the HIV
clinics and 183 newly diagnosed HIV+ at baseline. Of those, 364
participants from the hospital-based clinics were taking ART and
completed questions needed for this analysis, as were 104 from
four free-standing voluntary HIV counselling and testing sites and
completed questions needed for this analysis. Three of the latter
tested HIV- at baseline, but seroconverted and started taking
medication prior to the 36-month interview.
Participants completed detailed interviews with trained, field-
certified interviewers at six-month intervals. The 36-month survey
was used in these analyses because it included the most extensive
measurements relevant to the research question.
Measures
Potentially traumatic events
The number of types of lifetime potentially traumatic events is a
widely used trauma assessment that has been associated with
multiple negative health outcomes [18,19,20,21,22]. The Life
Events Checklist is used in conjunction with the system checklist
described below to screen for and diagnosis anxiety and PTSD.
The assessment measured 15 types of experiences including sexual
and physical abuse, childhood physical and emotional neglect, and
11 other potentially traumatic childhood and adulthood experi-
ences [23,24,25,26]. The score ranges from 0 to 15, reflecting the
number of types of potentially traumatic events experienced in the
participant’s lifetime.
Sexual abuse is defined in the scales to include sexual
experiences (e.g., touching, intercourse) where force or threat of
force was used; additionally, in children before the age of puberty
the threat of force or harm was implied by a 5-year age difference
between victim and perpetrator. Physical abuse was defined as
incidents separate from sexual abuse in that they (1) were
perceived to be life threatening (being physically attacked with
the intent to kill or seriously injure), or (2) identified as other
physical attacks in which victims were being beaten, hit, kicked,
bit, or burned. Childhood physical and emotional neglect were
measured with the Childhood Trauma Questionnaire and scored
using cut-offs suggested by Bernstein and Fink for moderate
physical neglect ($9) and moderate emotional neglect ($12) [26].
Additional childhood trauma assessments included the following
events prior to age 18: (1) parental alcohol/drug abuse, (2)
parental mental illness or parental suicide/attempted suicide, (3)
imprisonment of a parent, (4) domestic violence/threat in the
home, (5) child was placed in reform school/foster care/
orphanage or was put up for adoption, (6) imprisonment of child,
(7) homicide of a close family member/friend, (8) death of an
immediate family member not due to homicide or suicide, and (9)
child suffered from a life-threatening illness/injury not related to
HIV. Additional potentially traumatic events assessed from
adulthood included (1) homicide of a close family member/friend,
(2) non-homicidal death of a child, and (3) non-homicidal death of
a spouse/partner.
Post-traumatic stress disorder symptoms
Post-traumatic stress disorder (PTSD) symptom severity was
assessed with the PTSD Symptoms Checklist (PCL) based on
DSM-IV criteria that include re-experiencing a traumatic event,
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numbing/avoiding, and hyperarousal symptoms. The scale is
scored on a range of 0–68 with higher scores indicating greater
PTSD symptomatology; it has strong reliability and correlation
with a clinician-administered PTSD measure [27,28].
Depression
Depressive severity was measured using the Patient Health
Questionnaire (PHQ) -9, a depression case identification tool that
has been widely used and validated, including in SSA. The scale’s
total score can range between 0 and 27 with a higher score
indicating greater depressive severity [29, 30]. The PHQ-9 is used
by clinicians to monitor depression treatment over time.
Sociodemographic characteristics
Age, gender, level of education, and marital status, were
measured via self-report.
Household wealth
A wealth index was calculated for each household consisting of
assets and living environment characteristics, including rural vs.
urban living status, by applying to each component variable its
estimated contribution to the 2010 Tanzania Demographic and
Health Survey (DHS) wealth index [31]. A linear regression
model predicted DHS wealth scores as a function of indicator
variables for the presence of electricity, radio, television,
motorbike, car, clock/watch, refrigerator, mobile phone, and/
or non-mobile phone in the household; pipe-borne drinking
water on the property, variables describing the toilet facility (flush
toilet vs. other), natural vs. rudimentary floor construction, and
whether the household is located in a rural or urban area.
Parameter estimates were used to predict a wealth score for each
CHAT household as a linear combination of the parameters for
each covariate.
Economic difficulties related to health care
We assessed the economic burden of ART, which was
previously shown to affect adherence to ART in Tanzania [12].
Participants were asked whether they had to go without necessities
such as food, clothes, or housing in order to use the money for
health care or medications. To understand the burden of travel to
care, participant’s current address was used to generate a binary
variable that indicates rural residence in contrast to urban
residence or mixed area. For 60 participants for whom address
was not available at 36 months, records at 42 months were used
instead. Participants rarely moved during the study period.
Adherence to ART medication
Among study participants prescribed ART, adherence was
assessed with three self-report questions. First, each participant
was asked a single item from the AIDS Clinical Trial Group
adherence assessment [32], namely when the last time was that
s/he had missed a dose of his/her antiretrovirals, with response
options of never, within the past week, 1–2 weeks ago, 3–4 weeks
ago, 1–3 months ago, or more than 3 months ago. Next, the
participant was asked to show, on a 0–100% visual analog scale,
(1) the percentage of their antiretroviral drugs they had taken in
the last month and (2) the percentage of their antiretroviral drugs
they had missed in the last month. Participants were classified as
adherent if they reported not missing doses (1 and 2).
Participants with strongly inconsistent answers to the questions
on doses taken and doses missed in the last month were excluded
(N = 7).
Variables Not Included
The CHAT study collected information on other variables that
have been seen in other studies to predict non-adherence;
however, there was too little variation to be included in these
analyses.
Pill Burden. Most participants took one or two pills per day
and there was not a statistically significant difference in pill
burden. In absolute numbers, those who reported perfect
adherence had a higher pill burden than those who reported
non-adherence. For example, 58% of those reporting perfect
adherence took 1 or 2 pills per day relative to 54% of those
reporting non-adherence. Eleven percent of perfect adherers took
5 or more pills per day compared to 6% of non-adherers.
Negative Side Effects. Only 6 participants reported missing
medication doses due to negative side effects from medications,
precluding the use of the variable as a predictor.
Alcohol Abuse. Reported alcohol use was quite low in this
HIV+ population on treatment. Only 2% (1% of the adherence
group, 10% of the non-adherent group) reported drinking more
than once per week. The mean AUDIT score was 0.5 on a scale of
0–10 (0.4 for adherent group, 1.1 for non-adherent group).
Statistical Analysis
Means or proportions were compared between established and
newly diagnosed HIV patients and between those with complete
and incomplete adherence using the Student’s t test or the chi-
square test respectively. A multivariate Poisson regression model
was constructed using potential predictors of adherence, identi-
fied a priori based on those characteristics demonstrated to be
predictive of medication adherence in previous research and
based on the study hypotheses. With the binary outcome
variable, exponentiated coefficients from the Poisson model are
interpretable as risk ratios [33]. Log-binomial models were tested,
but did not converge due to small numbers. In addition to
demographic and socioeconomic characteristics (age, gender,
marital status, education, household wealth, sacrifice of other
necessities for healthcare, and rural vs. urban residence), the
multivariate regression model included the experience of
traumatic events in childhood and separately in adulthood,
recent stressful life events, post-traumatic stress symptomatology,
depression, social support, time since ART initiation, and a
binary variable indicating established vs. newly diagnosed HIV
patients. For multivariate regression, we rescaled age so that risk
ratios reflected the predicted differences between 5 year age
increments. Due to small numbers, childhood traumatic experi-
ences were grouped together in the multivariate model as were
adult experiences. The multivariate model was run with and
without PTSD as a variable in order to tease out the effect of
childhood trauma as mediated by PTSD.
Statistical analyses were conducted using Stata software, version
11.2 (StataCorp).
Results
Of 547 established and newly diagnosed patients who reported
valid answers regarding all covariates used in this analysis, 468
(85.6%) were prescribed ART (Table 1). Approximately three-
quarters (78%) were prescribed ART regimens considered first-
line therapy according to the 2009 Tanzanian treatment
guidelines with once or twice daily dosing [34]. Among those on
ART, 82.7% reported complete adherence to ART regimen, and
17.3% reported incomplete adherence. There were no statistically
significant differences in demographic and economic characteris-
tics between those adherent and non-adherent to medications: the
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average age was 41.8; males comprised 29.5% of the population;
38.9% of participants were married or cohabitating, 30.3% were
widowed, and 19.0% divorced or separated; 5.8% of participants
reported no formal education, 77.1% received only primary school
education, and 17.1% had attended secondary school or higher;
53.0% of participants resided in rural area; and average household
wealth estimated 9.8 on a scale from to 27.2 to 30, with a higher
score indicating a wealthier household.
Statistically significant differences were found in the percent
reporting that they sacrificed other necessities for health care needs
(24.5% vs. 13.6%: p-value ,0.05) and the mean time since ART
initiation (55 months vs. 44 months: (p-value ,0.01) between
those reporting medication adherence and those reporting
incomplete adherence.
Table 2 reports the distribution of types of traumatic events,
post-traumatic stress symptomatology, depressive symptom sever-
ity, recent stressful life events, and social support. Those not
completely adherent to ART reported a mean of 2.5 types of
potentially traumatic events, compared with a mean of 2.1 in the
completely adherent group. In particular, those with incomplete
adherence to ART were more likely than those who were
completely adherent to have experienced sexual abuse prior to
puberty (17.5% vs. 6.8%: p-value ,0.01) and the death of an
immediate family member not due to homicide or suicide (64.2 vs.
51.7%: p-value ,0.05). In addition, those who were incompletely
adherent had higher post-traumatic stress (p-value ,0.01) and
depressive symptomatology (p-value ,0.01) scores and less social
support (p-value ,0.01) than those who reported complete
adherence. Twenty-five percent of the non-adherent group had
PHQ-9 scores of 5 or more (compared to a score of 2 for the
adherent group), an indication of ‘‘mild depression,’’ with the
highest score for this group being 23.
Multivariate Analysis
In a multivariate Poisson regression model (see Table 3) that
controlled for each participant’s gender, age, marital status,
education, household wealth, rural vs. urban residence, status as
an established vs. newly diagnosed HIV patient, time since ART
initiation, number of types of adulthood traumatic experiences,
number of recent stressful life events, PTSD symptomology, and
social support, we found that incomplete ART adherence was
statistically significantly positively associated with the experience of
childhood traumatic events and PHQ-9 depressive symptom
severity. Incomplete adherence showed a trend toward negative
association with sacrifice of other necessities for health care needs
(meaning those with complete adherence were more likely to
report making such sacrifices).
Each additional childhood traumatic experience was associated
with a 13% increase in the risk of incomplete ART adherence
(risk ratio = 1.13; p-value ,0.05). Each additional 1-unit
increase on the 27-point PHQ-9 depressive symptom severity
score was associated with a 9% increase in the risk of incomplete
ART adherence (risk ratio = 1.09; p-value ,0.01). Conversely,
sacrifice of other necessities for health care was associated with a
48% decrease in the risk of incomplete ART adherence (risk
ratio = 0.52; p-value = 0.06), suggesting a protective association
between such financial sacrifice and ART adherence.
When the model excluded PTSD, the risk ratio for childhood
trauma changed only marginally, indicating that PTSD mediated
little or none of the relationship between childhood trauma and
incomplete adherence. These results suggest that childhood
trauma influences incomplete adherence independently of PTSD
symptomatology.
Alternate regression models alternatively included binary
variables for: childhood sexual abuse, an immediate family
member of participant’s died not due to human action during
participant’s childhood, and a refined continuous variable that
indicates the number of types of traumas participant experienced
Table 1. Sociodemographic Sample Description.
HIV + Sample on HIV Medications
Total Adherent Non-Adherent p-value
N = 468 N = 387 N = 81
Age, Mean (SD) 41.8 (8.4) 42.0 (8.4) 40.7 (8.3) 0.215
Male gender 29.49% 29.72% 28.40% 0.813
Marital status
Married/cohabitating 38.89% 39.53% 35.80% 0.532
Never married 11.75% 11.63% 12.35% 0.856
Widowed 30.34% 29.97% 32.10% 0.706
Divorced/separated 19.02% 18.86% 19.75% 0.853
Highest level of education achieved
None 5.77% 6.20% 3.70% 0.382
Primary school (1–6 years) 77.14% 76.49% 80.25% 0.465
Secondary school or higher 17.09% 17.31% 16.05% 0.784
Sacrifice of other necessities for healthcare 22.44% 24.29% 13.58% 0.036
Rural residence 52.99% 54.52% 45.68% 0.148
DHS wealth index, Mean (SD) 9.8 (9.5) 9.8 (9.5) 9.8 (9.5) 0.952
Time in months since ART initiation, Mean (SD) 52.8 (22.6) 54.7 (22.6) 44.1 (20.7) 0.000
Established (vs. recently diagnosed) HIV patient 77.78% 81.65% 59.26% 0.000
doi:10.1371/journal.pone.0074771.t001
Incomplete Adherence to ART in Tanzania
PLOS ONE | www.plosone.org 4 October 2013 | Volume 8 | Issue 10 | e74771
among the other types of childhood trauma. The direction and
scale of coefficients were intuitively right but due to the small
sample size, two of three did not have enough statistical power to
show significance. Childhood sexual abuse was positively associ-
ated with incomplete adherence to ART with a trend towards
statistical significance (RR = 1.57, p,0.1), an immediate family
member of participant’s died not due to homicide or suicide
during participant’s childhood was statistically significantly posi-
tively associated with incomplete adherence to ART (RR = 1.50,
p,0.05), and the number of other types of trauma participant
experienced during childhood was positively associated with
incomplete adherence to ART (RR = 1.05) but was not statistical
significant.
Discussion
This study indicates that mental health symptomatology and the
sequelae of past trauma are associated with non-HIV medication
adherence: conditions which could be treated in conjunction with
HIV. With the estimated $16.8 billion being spent globally on HIV
in 2011 and a goal of increasing spending to $22 to $24 billion by
2015 [35] there is growing recognition that we need to focus not just
on availability of medications, but also on adherence to medications
and retention in care [3]. This study indicates that expanding HIV
services to include mental health services would result in higher
levels of medication adherence. Relatively inexpensive and
manualized mental health treatment protocols for depression and
anxiety are being developed and tested in low income countries and
could be feasibly integrated with HIV care.
People non-adherent to medications were on HIV medications
for a shorter period of time and this variable was significant in one of
the two multivariable models. The reason for this difference may be
because people who have been on treatment and engaged in care
for a longer period of time are more likely have gained a trusting
relationship with providers, or, as others have hypothesized,
because those who were the first to have access to ART in low
income countries were those who were most motivated to adhere to
Table 2. Life Events, Mental Health Symptomatology and Social Support.
HIV+ Sample on HIV Medications
Total Adherent Non-Adherent p-value
N = 468 N = 387 N = 81
Traumatic events
Childhood trauma category
Mean experienced (SD) 2.2 (1.5) 2.1 (1.5) 2.5 (1.4) 0.061
Sexual abuse before puberty 8.66% 6.81% 17.50% 0.002
Physical abuse or assault before 13 years old 3.63% 3.36% 4.94% 0.491
Parental alcoholism or use of drugs 59.62% 60.98% 53.09% 0.189
Parental mental illness, suicide, or suicide attempt 9.83% 9.30% 12.35% 0.404
Parent or caregiver went to prison 9.40% 8.79% 12.35% 0.319
Parental fighting and threats 31.20% 31.52% 29.63% 0.738
Emotional neglect 8.97% 9.04% 8.64% 0.909
Physical neglect 20.30% 19.12% 25.93% 0.167
In orphanage/foster care/reformatory/put up for adoption 1.71% 1.55% 2.47% 0.563
Imprisonment for one week or longer 2.99% 2.84% 3.70% 0.680
Life-threatening illness or injury 6.62% 5.68% 11.11% 0.074
Death of immediate family member not due to human action 53.85% 51.68% 64.20% 0.040
Death of a close person due to other person 1.92% 2.07% 1.23% 0.621
Adulthood trauma category
Mean experienced (SD) 1.0 (0.9) 1.1 (0.9) 1.0 (0.9) 0.652
Sexual abuse since puberty 13.42% 13.09% 15.00% 0.649
Physical abuse or assault since 13 years old 7.26% 6.98% 8.64% 0.600
Death of a close person due to other person 14.32% 14.73% 12.35% 0.579
Death of a child 33.12% 34.11% 28.40% 0.321
Death of spouse or partner 36.32% 36.43% 35.80% 0.915
Lifetime trauma category 3.3 (2.0) 3.3 (2.0) 3.5 (1.8) 0.405
Incident stress category, Mean experienced (SD) 2.3 (2.1) 2.3 (2.1) 2.3 (2.1) 0.824
Mental Health Symptomatology
PTSD symptomology (Scale range: 0–68), Mean (SD) 11.2 (9.0) 10.5 (8.0) 14.9 (11.9) 0.000
PHQ-9 depressive severity (Scale range: 0–27), Mean (SD) 2.0 (2.9) 1.8 (2.6) 3.3 (4.1) 0.000
Social Support (Scale range: 0–76), Mean (SD) 57.5 (18.8) 58.6 (18.8) 52.3 (18.3) 0.006
Note: Incident stress category excludes (1) those overlapping with adulthood trauma and (2) income or employment-related stress.
doi:10.1371/journal.pone.0074771.t002
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the medications and were seeking the medications. As medications
become more widely available, non-adherence may increase.
Those individuals with incomplete adherence had greater
depressive symptoms as measured by the PHQ-9. Similar to
findings from our studies in the U.S., people reporting incomplete
adherence endorsed prior exposure to more types of childhood
potentially traumatic experiences, notably childhood sexual abuse
[22]. In multivariable models, childhood trauma and depressive
symptom severity were highly significant predictors of incomplete
ART adherence.
In interpreting the results of this study, we note several
limitations. Many of the measured variables, including ART
adherence and exposure to traumatic events symptoms, were
measured by self-report. These reports may have been subject to
recall bias since most traumatic events occurred years prior to the
study interviews. Further, traumatic events may have been under-
reported due to reluctance to mention difficult experiences.
Conservative cut-off points were used in defining ART adherence.
The observational design of the study limits the causal interpre-
tation of these results.
Limitations notwithstanding, it is impressive that mental health
symptomatology and trauma sequelea are more predictive of HIV
medication adherence than the sociodemographic and economic
barriers. While HIV related services are still being created in
LMICs, we have a window of opportunity to integrate HIV
services with mental health related services. Our findings suggest
that exposure to potentially traumatic events and severity of
depressive symptoms negatively affect ART adherence in a sub-
Saharan African population. There are effective intervention
strategies in the U.S. that improve outcomes in HIV+ individuals
who have been exposed to traumatic events [36,37,38]. Further,
treatments for depression, including psychotherapeutic and
pharmacologic interventions, have proven effective in improving
ART adherence in a number of studies in the US and Switzerland.
Small studies of psychotherapeutic interventions in similarly
resource-constrained sub-Saharan African settings have demon-
strated that interventions for depression are acceptable and
effective [39,40,41,42]. As treatment interventions for HIV
continue to be rolled out in sub-Saharan Africa, and as the
burden of mental illness is increasingly recognized both in its own
right and as it relates to prognosis and management of other
illnesses, it is essential to understand barriers to care and to identify
potential areas for intervention that would facilitate more effective
HIV care for millions of people. Allocation of funding in HIV
programs such as PEPFAR and the Global Fund to integrate
evidence-based interventions to reduce the impact of psychosocial
stressors, in particular trauma-related stress, has the potential to
greatly impact ART adherence and overall health in HIV-infected
individuals.
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Never married 0.88 0.46, 1.67 0.688 0.87 0.45, 1.67 0.676
Widowed 1.23 0.72, 2.10 0.447 1.16 0.67, 2.01 0.605
Divorced/separated 0.98 0.56, 1.70 0.942 0.92 0.52, 1.62 0.763
Highest education level achieved (ref = primary school)
None 0.40 0.15, 1.05 0.064 0.45 0.18, 1.12 0.087
Secondary school or more 1.00 0.61, 1.64 0.986 1.00 0.61, 1.63 0.996
Sacrifice of other necessities for healthcare 0.51 0.26, 1.03 0.061 0.52 0.26, 1.03 0.062
DHS wealth index (per additional unit) 1.01 0.98, 1.03 0.647 1.01 0.98, 1.03 0.554
Rural (vs. urban/mixed area) residence 0.72 0.49, 1.06 0.098 0.71 0.48, 1.06 0.091
Established (vs. newly diagnosed) HIV patient 0.67 0.42, 1.07 0.094 0.62 0.38, 1.02 0.059
Social support (per additional unit) 0.99 0.98, 1.00 0.159 0.99 0.98, 1.00 0.201
doi:10.1371/journal.pone.0074771.t003
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